Labetalol Dosing for Mild Hypertension at 32 Weeks Gestation

Blood Pressure Classification and Treatment Threshold

• The American College of Cardiology recommends treating blood pressure consistently ≥140/90 mmHg to reduce the likelihood of developing severe maternal hypertension and complications, for a pregnant woman at 32 weeks with blood pressure 140/90 mmHg 1

Target Blood Pressure

• Aim for systolic BP 110-140 mmHg and diastolic BP 85-90 mmHg, and never reduce diastolic BP below 80 mmHg, as this can impair uteroplacental perfusion and compromise fetal development, according to the European Society of Cardiology 1
• If diastolic BP falls below 80 mmHg, reduce or cease antihypertensive medication, as recommended by the American Heart Association 1

Monitoring Requirements

• Maternal monitoring should include BP checks at least twice weekly initially, then weekly once stable, and assess for proteinuria at each visit, according to the American College of Obstetricians and Gynecologists 1
• Fetal monitoring should include initial ultrasound to confirm fetal well-being, as recommended by the International Society for the Study of Hypertension in Pregnancy 1

When to Escalate Care

• Immediate hospitalization is required if BP reaches ≥160/110 mmHg, and switch to IV labetalol, as recommended by the European Society of Cardiology 3
• Alternative treatments include oral nifedipine or IV hydralazine if labetalol is contraindicated, according to the American Heart Association 3

Delivery Planning

• Plan delivery at 37 weeks and 0 days if hypertension remains stable, as recommended by the American College of Obstetricians and Gynecologists 1
• Deliver earlier if any of the following develop, such as repeated severe hypertension despite 3 antihypertensive classes, according to the International Society for the Study of Hypertension in Pregnancy 1

Safety Profile and Contraindications

• Labetalol is safe and effective for pregnancy hypertension, but avoid it if the patient has second or third-degree AV block, maternal systolic heart failure, or severe asthma, as recommended by the European Society of Cardiology 3
• Potential side effects include neonatal bradycardia, maternal bronchoconstriction, and postural hypotension, according to the American Heart Association 3

Alternative First-Line Agents

• If labetalol is contraindicated or not tolerated, acceptable alternatives include methyldopa, long-acting nifedipine, or oxprenolol, as recommended by the American College of Cardiology 1